Industry: Pharma & Healthcare
Published Date: 2026-01-04
Pages: 123 Pages
Report ld: 5534558
Request Sample
Customized Report
Metronidazole Market Size(US$)

CAGR 2026-2032
-0.46%
Market Size,2032
USD 108
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Metronidazole competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.
China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.
In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.
This report delivers a comprehensive overview of the global Metronidazole market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Metronidazole. The Metronidazole market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Metronidazole market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Metronidazole manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Metronidazole manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Metronidazole sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Metronidazole Market Overview
1.1 Product Definition
1.2 Metronidazole by Type
1.2.1 Global Metronidazole Market Value by Type: 2025 vs 2032
1.2.2 Glyoxal Process
1.2.3 Ethidene Diamine Process
1.2.4 Others
1.3 Metronidazole by Application
1.3.1 Global Metronidazole Market Value by Application: 2025 vs 2032
1.3.2 Metronidazole Tablets
1.3.3 Metronidazole Capsule
1.3.4 Metronidazole Injection
1.3.5 Others
1.4 Global Metronidazole Market Size Estimates and Forecasts
1.4.1 Global Metronidazole Revenue 2021–2032
1.4.2 Global Metronidazole Sales 2021–2032
1.4.3 Global Metronidazole Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Metronidazole Market Competition by Manufacturers
2.1 Global Metronidazole Sales Market Share by Manufacturers (2021–2026)
2.2 Global Metronidazole Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Metronidazole Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Metronidazole, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Metronidazole, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Metronidazole, Product Types and Applications
2.7 Global Key Manufacturers of Metronidazole, Date of Entry into the Industry
2.8 Global Metronidazole Market Competitive Situation and Trends
2.8.1 Global Metronidazole Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Metronidazole Players Market Share by Revenue
2.8.3 Global Metronidazole Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Metronidazole Market Scenario by Region
3.1 Global Metronidazole Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Metronidazole Sales by Region: 2021–2032
3.2.1 Global Metronidazole Sales by Region: 2021–2026
3.2.2 Global Metronidazole Sales by Region: 2027–2032
3.3 Global Metronidazole Revenue by Region: 2021–2032
3.3.1 Global Metronidazole Revenue by Region: 2021–2026
3.3.2 Global Metronidazole Revenue by Region: 2027–2032
3.4 North America Metronidazole Market Facts & Figures by Country
3.4.1 North America Metronidazole Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Metronidazole Sales by Country (2021–2032)
3.4.3 North America Metronidazole Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Metronidazole Market Facts & Figures by Country
3.5.1 Europe Metronidazole Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Metronidazole Sales by Country (2021–2032)
3.5.3 Europe Metronidazole Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metronidazole Market Facts & Figures by Region
3.6.1 Asia Pacific Metronidazole Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Metronidazole Sales by Region (2021–2032)
3.6.3 Asia Pacific Metronidazole Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Metronidazole Market Facts & Figures by Country
3.7.1 Latin America Metronidazole Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Metronidazole Sales by Country (2021–2032)
3.7.3 Latin America Metronidazole Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metronidazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Metronidazole Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Metronidazole Sales by Country (2021–2032)
3.8.3 Middle East and Africa Metronidazole Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Metronidazole Sales by Type (2021–2032)
4.1.1 Global Metronidazole Sales by Type (2021–2026)
4.1.2 Global Metronidazole Sales by Type (2027–2032)
4.1.3 Global Metronidazole Sales Market Share by Type (2021–2032)
4.2 Global Metronidazole Revenue by Type (2021–2032)
4.2.1 Global Metronidazole Revenue by Type (2021–2026)
4.2.2 Global Metronidazole Revenue by Type (2027–2032)
4.2.3 Global Metronidazole Revenue Market Share by Type (2021–2032)
4.3 Global Metronidazole Price by Type (2021–2032)
5 Segment by Application
5.1 Global Metronidazole Sales by Application (2021–2032)
5.1.1 Global Metronidazole Sales by Application (2021–2026)
5.1.2 Global Metronidazole Sales by Application (2027–2032)
5.1.3 Global Metronidazole Sales Market Share by Application (2021–2032)
5.2 Global Metronidazole Revenue by Application (2021–2032)
5.2.1 Global Metronidazole Revenue by Application (2021–2026)
5.2.2 Global Metronidazole Revenue by Application (2027–2032)
5.2.3 Global Metronidazole Revenue Market Share by Application (2021–2032)
5.3 Global Metronidazole Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Hongyuan Pharmaceutical
6.1.1 Hongyuan Pharmaceutical Company Information
6.1.2 Hongyuan Pharmaceutical Description and Business Overview
6.1.3 Hongyuan Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Hongyuan Pharmaceutical Metronidazole Product Portfolio
6.1.5 Hongyuan Pharmaceutical Recent Developments/Updates
6.2 Yinhe Aarti Pharmaceutical
6.2.1 Yinhe Aarti Pharmaceutical Company Information
6.2.2 Yinhe Aarti Pharmaceutical Description and Business Overview
6.2.3 Yinhe Aarti Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Yinhe Aarti Pharmaceutical Metronidazole Product Portfolio
6.2.5 Yinhe Aarti Pharmaceutical Recent Developments/Updates
6.3 Saikang Pharmaceutical
6.3.1 Saikang Pharmaceutical Company Information
6.3.2 Saikang Pharmaceutical Description and Business Overview
6.3.3 Saikang Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Saikang Pharmaceutical Metronidazole Product Portfolio
6.3.5 Saikang Pharmaceutical Recent Developments/Updates
6.4 Zhongan Pharmaceutical
6.4.1 Zhongan Pharmaceutical Company Information
6.4.2 Zhongan Pharmaceutical Description and Business Overview
6.4.3 Zhongan Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zhongan Pharmaceutical Metronidazole Product Portfolio
6.4.5 Zhongan Pharmaceutical Recent Developments/Updates
6.5 Wuyao Pharmaceutical
6.5.1 Wuyao Pharmaceutical Company Information
6.5.2 Wuyao Pharmaceutical Description and Business Overview
6.5.3 Wuyao Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Wuyao Pharmaceutical Metronidazole Product Portfolio
6.5.5 Wuyao Pharmaceutical Recent Developments/Updates
6.6 Yichang Changjiang Pharmaceutical
6.6.1 Yichang Changjiang Pharmaceutical Company Information
6.6.2 Yichang Changjiang Pharmaceutical Description and Business Overview
6.6.3 Yichang Changjiang Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Yichang Changjiang Pharmaceutical Metronidazole Product Portfolio
6.6.5 Yichang Changjiang Pharmaceutical Recent Developments/Updates
6.7 Tongji Pharmaceutical
6.7.1 Tongji Pharmaceutical Company Information
6.7.2 Tongji Pharmaceutical Description and Business Overview
6.7.3 Tongji Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Tongji Pharmaceutical Metronidazole Product Portfolio
6.7.5 Tongji Pharmaceutical Recent Developments/Updates
6.8 Hongda Pharmaceutical
6.8.1 Hongda Pharmaceutical Company Information
6.8.2 Hongda Pharmaceutical Description and Business Overview
6.8.3 Hongda Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hongda Pharmaceutical Metronidazole Product Portfolio
6.8.5 Hongda Pharmaceutical Recent Developments/Updates
6.9 Topsun Pharmaceutical
6.9.1 Topsun Pharmaceutical Company Information
6.9.2 Topsun Pharmaceutical Description and Business Overview
6.9.3 Topsun Pharmaceutical Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Topsun Pharmaceutical Metronidazole Product Portfolio
6.9.5 Topsun Pharmaceutical Recent Developments/Updates
6.10 Unichem Laboratories
6.10.1 Unichem Laboratories Company Information
6.10.2 Unichem Laboratories Description and Business Overview
6.10.3 Unichem Laboratories Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Unichem Laboratories Metronidazole Product Portfolio
6.10.5 Unichem Laboratories Recent Developments/Updates
6.11 CordenPharma Farchemia
6.11.1 CordenPharma Farchemia Company Information
6.11.2 CordenPharma Farchemia Description and Business Overview
6.11.3 CordenPharma Farchemia Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 CordenPharma Farchemia Metronidazole Product Portfolio
6.11.5 CordenPharma Farchemia Recent Developments/Updates
6.12 API Polpharma
6.12.1 API Polpharma Company Information
6.12.2 API Polpharma Description and Business Overview
6.12.3 API Polpharma Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 API Polpharma Metronidazole Product Portfolio
6.12.5 API Polpharma Recent Developments/Updates
6.13 Manav Drugs
6.13.1 Manav Drugs Company Information
6.13.2 Manav Drugs Description and Business Overview
6.13.3 Manav Drugs Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Manav Drugs Metronidazole Product Portfolio
6.13.5 Manav Drugs Recent Developments/Updates
6.14 Aarey Drugs & Pharmaceuticals
6.14.1 Aarey Drugs & Pharmaceuticals Company Information
6.14.2 Aarey Drugs & Pharmaceuticals Description and Business Overview
6.14.3 Aarey Drugs & Pharmaceuticals Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Aarey Drugs & Pharmaceuticals Metronidazole Product Portfolio
6.14.5 Aarey Drugs & Pharmaceuticals Recent Developments/Updates
6.15 Aarti Drugs
6.15.1 Aarti Drugs Company Information
6.15.2 Aarti Drugs Description and Business Overview
6.15.3 Aarti Drugs Metronidazole Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Aarti Drugs Metronidazole Product Portfolio
6.15.5 Aarti Drugs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metronidazole Industry Chain Analysis
7.2 Metronidazole Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metronidazole Production Mode & Process Analysis
7.4 Metronidazole Sales and Marketing
7.4.1 Metronidazole Sales Channels
7.4.2 Metronidazole Distributors
7.5 Metronidazole Customer Analysis
8 Metronidazole Market Dynamics
8.1 Metronidazole Industry Trends
8.2 Metronidazole Market Drivers
8.3 Metronidazole Market Challenges
8.4 Metronidazole Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 93
USD 4250.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 168
USD 4900.00
(Single User License)
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 154
USD 5900.00
(Single User License)
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 123
USD 3950.00
(Single User License)
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published Date: 2025-01-16
Pages: 95
USD 2900.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-17
Pages: 179
USD 5600.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-16
Pages: 170
USD 5900.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-07
Pages: 115
USD 4900.00
(Single User License)
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 93
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 168
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 154
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 123
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published: 2025-01-16
Pages: 95
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-17
Pages: 179
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-16
Pages: 170
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-07
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now